Cannabist

Cannabist

Patient-center healthcare company setting th standard of care for medical marijuana.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor

€0.0

Valuation: €0.0

4.1x EV/Revenue

31.3x EV/EBITDA

round
N/A

€0.0

round
*
N/A

$19.5m

Post IPO Convertible
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues0000000000000000000000000000
% growth134 %163 %8 %-(10 %)(25 %)-
EBITDA0000000000000000000000000000
% EBITDA margin(2 %)18 %13 %14 %12 %11 %15 %
Profit0000000000000000000000000000
% profit margin(62 %)(30 %)(81 %)(34 %)-(44 %)(23 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article, Equity research estimates

Notes (0)
More about Cannabist
Made with AI
Edit

The Cannabist Company, which rebranded from its original name Columbia Care in 2023, stands as a significant entity in the American cannabis sector. It operates as a vertically integrated company, involved in the cultivation, manufacturing, and retail of cannabis products. The firm was co-founded by Michael Abbott and Nicholas Vita, who have served as Executive Co-Chairmen. Their professional backgrounds are rooted in finance and investment, with both having held significant roles at institutions like Goldman Sachs. This experience in highly regulated and complex markets provided a solid foundation for navigating the intricate legal and financial landscape of the U.S. cannabis industry.

The company's journey began with a focus on the medical cannabis market, establishing itself as an early provider in the United States. This patient-centric approach has since broadened to encompass the adult-use recreational market, reflecting the evolving legal framework across the country. The business model involves direct-to-consumer sales through its network of dispensaries, branded as Cannabist. These retail locations are designed to provide an educational and accessible experience for both medicinal patients and recreational consumers. Revenue is generated through the sale of a diverse portfolio of cannabis products.

The Cannabist Company's product offerings cover various consumption methods, including traditional flower, edibles, oils, and tablets. It has developed and markets several in-house brands to cater to different consumer segments. These brands include Seed & Strain, which focuses on cannabis flower, and Hedy, which is a line of edibles. By controlling the process from seed to sale, the company aims to ensure product quality and consistency across its operations. This vertical integration also allows it to capture margin at each stage of the value chain, from cultivation to final retail sale.

Keywords: cannabis, vertical integration, medical cannabis, adult-use cannabis, dispensary retail, cannabis cultivation, consumer packaged goods, cannabis manufacturing, brand portfolio, seed-to-sale

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Cannabist

Edit
Green Leaf Medical
ACQUISITION by Cannabist Dec 2020
Medicine Man Denver
ACQUISITION by Cannabist Jun 2021
The Green Solution
ACQUISITION by Cannabist Sep 2020
Project Cannabis
ACQUISITION by Cannabist Dec 2020
CannAscend
ACQUISITION by Cannabist Jul 2021